PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 12, 2026Lasers in Medical Science0 citationsOpen Access

`Effect of adjunctive antimicrobial photodynamic therapy on periapical healing and IL-6 modulation in apical periodontitis: a pilot randomized controlled study

MKManoj KumarRBRamesh BhartiPVPromila Verma

Key Points

  • This research aims to evaluate the effects of adjunctive antimicrobial photodynamic therapy on IL-6 levels and periapical healing in apical periodontitis.
  • Conducted as a pilot randomized controlled trial over 11 months.
  • Participants aged 18-40 with apical periodontitis were randomized to receive either NaOCl or adjunctive aPDT.
  • Primary outcome assessed was the change in IL-6 levels from baseline to 6 months; secondary outcomes included symptom resolution and radiographic healing.
  • Change in IL-6 levels was similar between groups for serum and GCF samples with p-values of 0.230 and 0.551 respectively.
  • Radiographic healing was significantly better in the aPDT group with a median CBCT-PAI score of 3 compared to 4 in the NaOCl group (p = 0.014).
  • Both groups had comparable rates of symptom resolution.

Abstract

Apical periodontitis (AP) is characterized by elevated IL-6 levels and periapical bone resorption. Antimicrobial photodynamic therapy (aPDT) is a promising adjunct to sodium hypochlorite (NaOCl) in root canal disinfection. This pilot randomized controlled trial evaluated the effect of adjunctive aPDT on IL-6 modulation and periapical healing in AP. This 11-month, parallel two-arm pilot randomized controlled study was conducted in a tertiary care hospital in North India (February–December 2024). Participants of AP, aged 18–40 years with single-rooted teeth, were randomized (1:1) to Group A (NaOCl disinfection) or Group B (adjunctive aPDT). The primary outcome was change in IL-6 levels (serum, GCF) from baseline to 6 months. Secondary outcomes were symptom resolution and radiographic healing (CBCT-PAI). Of 44 patients screened, 34 were randomized (17 per group). Two participants in the aPDT group were lost to follow-up. At 6 months, change in IL-6 levels was similar in serum (–0.09 ± 0.71 pg/ml vs. − 0.11 ± 0.70 pg/ml; p = 0.230) and GCF (0.01 ± 0.01 vs. − 0.01 ± 0.06 pg/ml; p = 0.551). Median CBCT-PAI scores were lower in the aPDT group 4 (3–5) vs. 3 (2–4); p = 0.014, with significance maintained on ITT analysis (p = 0.045). Both groups showed comparable symptom resolution. Adjunctive aPDT was comparable to NaOCl alone for IL-6 modulation and symptom relief but demonstrated superior radiographic healing. As a pilot trial, these findings provide preliminary evidence; larger definitive studies are warranted. Trial registration: Clinical Trials Registry-India identifier: CTRI/2024/02/062262.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kumar et al. (2026) studied this question.

synapsesocial.com/papers/69b2581996eeacc4fcec7569https://doi.org/10.1007/s10103-026-04826-3
Ask AI
Helpful
Bookmark
Share
View Full Paper